CoChat

Neonatal and Pediatric Candidemia: Results From Population-Based Active Laboratory Surveillance in Four US Locations, 2009–2015

The DOI matches its Crossref record; 48 of the 49 references it cites were found in a registry or an index.

Abstract

INTRODUCTION: Candida is a leading cause of healthcare-associated bloodstream infections in the United States. Infants and children have unique risk factors for candidemia, and the Candida species distribution in this group is different that among adults; however, candidemia epidemiology in this population has not been described recently. METHODS: We conducted active population-based candidemia surveillance in 4 US metropolitan areas between 2009 and 2015. We calculated incidences among neonates (0-30 days old), infants (0-364 days old), and noninfant children (1-19 years old), documented their clinical features and antifungal drug resistance. RESULTS: We identified 307 pediatric candidemia cases. Incidence trends varied according to site, but overall, the incidence in neonates decreased from 31.5 cases/100000 births in 2009 to 10.7 to 11.8 cases/100000 births between 2012 and 2015, the incidence in infants decreased from 52.1 cases/100000 in 2009 to 15.7 to 17.5 between 2012 and 2015, and the incidence in noninfant children decreased steadily from 1.8 cases/100000 in 2009 to 0.8 in 2014. Common underlying conditions were prematurity in neonates (78%), surgery in nonneonate infants (38%), and malignancy in noninfant children (28%). Most neonate cases were caused by C albicans (67%), whereas non-C. albicans species accounted for 60% of cases in nonneonate infants and noninfant children. Fluconazole and echinocandin resistance rates were low overall. Thirty-day crude mortality was 13%. CONCLUSIONS: The incidence of candidemia among neonates and infants declined after 2009 but remained stable from 2012 to 2015. Antifungal drug resistance is uncommon. Reasons for the lack of recent declines in neonatal and infant candidemia deserve further exploration. In this article, we describe the epidemiology of candidemia in children in the United States and on the basis of data collected as part of US Centers for Disease Control and Prevention active population-based surveillance. Trends in incidence, clinical characteristics, species distribution, and resistance rates are presented.

Overview

Integrity signals

Registry

Crossref · 10.1093/jpids/piy009

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 48 references

Research works printed but not linked: 5

  1. CLSI document M27-A3, 2008, Clinical and Laboratory Standards Institute. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Approved Standard–third edition
  2. M27-S4, Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; 4th Informational Supplement
  3. National Center for Health Statistics, All-county birth data (2009–2015) as compiled from data provided by the 57 vital statistics jurisdictions through the Vital Statistics Cooperative Program
  4. Blyth, 2009, Not just little adults: candidemia epidemiology, molecular characterization, and antifungal susceptibility in neonatal and pediatric patients, Pediatrics, 123, 1360, 10.1542/peds.2008-2055 · DOI · Paper page
  5. Fanfair RN AA , FarleyM, et al Racial disparities in candidemia: results from population-based surveillance in the United States, 2008–2010. International Conference on Antimicrobials and Chemotherapeutics (ICAAC). Chicago, September 17–20, 2011.

Cited by

See all 85

Metadata

Authors
Benedict, K., Roy, M., Kabbani, S., Anderson, E. J., Farley, M. M., Harb, S., Harrison, L. H., Bonner, L., Wadu, V. L., Marceaux, K., Hollick, R., Beldavs, Z. G., Zhang, A. Y., Schaffner, W., Graber, C. R., Derado, G., Chiller, T. M., Lockhart, S. R., & Vallabhaneni, S.
Affiliations
  • Centers for Disease Control and Prevention (US)
  • Emory University (US)
  • Johns Hopkins University (US)
  • Maryland Emerging Infections Program, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland
  • Acute and Communicable Disease Prevention, Oregon Health Authority, Portland
  • Oregon Health Authority (US)
  • Vanderbilt University (US)
Corresponding author
Vallabhaneni, Snigdha
Venue
Journal of the Pediatric Infectious Diseases Society
Published
2018-03-07
Volume
7
Issue
3
Pages
e78-e85
ISSN
  • 2048-7193 (ISSN-L)
  • 2048-7207
OpenAlex
W2789278748
Cited by
81
References
49
Citations by year
2026: 8 · 2025: 9 · 2024: 15 · 2023: 7 · 2022: 8 · 2021: 16 · 2020: 9 · 2019: 5 · 2018: 3
FWCI
6.27
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of the Pediatric Infectious Diseases Society (publishedVersion, public-domain)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Neonatal and Maternal Infections
  • Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
Keywords
candidemia, neonatal candidemia, Candida albicans, non-albicans Candida, antifungal resistance, fluconazole resistance, echinocandin resistance, healthcare-associated bloodstream infections, preterm birth, mortality, risk factors, United States metropolitan areas, 2009 H1N1 influenza
MeSH terms
Adolescent, Antifungal Agents, Candida albicans, Child, Child, Preschool, Female, Humans, Infant, Infant, Newborn, Infant, Premature, Male, Population Surveillance, Prospective Studies, Risk Factors, United States, Fluconazole, Incidence, Drug Resistance, Fungal, Echinocandins, Young Adult, Candidemia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Neonatal and Pediatric Candidemia: Results From Population-Based Active Laboratory Surveillance in Four US Locations, 2009–2015. https://app.cochat.ai/papers/10.1093/jpids/piy009
The paper
Benedict, K., Roy, M., Kabbani, S., Anderson, E. J., Farley, M. M., Harb, S., Harrison, L. H., Bonner, L., Wadu, V. L., Marceaux, K., Hollick, R., Beldavs, Z. G., Zhang, A. Y., Schaffner, W., Graber, C. R., Derado, G., Chiller, T. M., Lockhart, S. R., & Vallabhaneni, S. (2018). Neonatal and Pediatric Candidemia: Results From Population-Based Active Laboratory Surveillance in Four US Locations, 2009–2015. Journal of the Pediatric Infectious Diseases Society. https://doi.org/10.1093/jpids/piy009

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.